Nonvalvular Atrial Fibrillation Clinical Trial
Official title:
First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation
This is the first in man study of E-SeaLATM developed and manufactured by Hangzhou Dinova EP Technology Co., Ltd, which can achieve pulsed field ablation and mechanical closure of the Left Atrial Appendage simultaneously, this study aims to initially verify the safety and efficacy of the device.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04586972 -
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
|
||
| Completed |
NCT02007655 -
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
|
||
| Completed |
NCT02674594 -
Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US
|
N/A | |
| Recruiting |
NCT04494347 -
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
|
N/A | |
| Not yet recruiting |
NCT04942873 -
The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
|
||
| Completed |
NCT01885598 -
Eliquis Regulatory Post Marketing Surveillance
|
N/A | |
| Completed |
NCT02919982 -
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
|
||
| Completed |
NCT00684307 -
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
|
Phase 2 | |
| Recruiting |
NCT04073316 -
AntiCoagulants and COGnition
|
Phase 4 | |
| Completed |
NCT03374540 -
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
|
||
| Recruiting |
NCT05715658 -
Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
|
N/A |